about
Multiple in vitro and in vivo regulatory effects of budesonide in CD4+ T lymphocyte subpopulations of allergic asthmatics.Th17 immunity in children with allergic asthma and rhinitis: a pharmacological approach.Cigarette smoke affects IL-17A, IL-17F and IL-17 receptor expression in the lung tissue: Ex vivo and in vitro studies.Cigarette smoke alters non-neuronal cholinergic system components inducing MUC5AC production in the H292 cell line.HLA-A, -B and -DRB1 allele frequencies in Cyrenaica population (Libya) and genetic relationships with other populations.Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing.Beclomethasone dipropionate and formoterol reduce oxidative/nitrosative stress generated by cigarette smoke extracts and IL-17A in human bronchial epithelial cells.Acetylcholine leads to signal transducer and activator of transcription 1 (STAT-1) mediated oxidative/nitrosative stress in human bronchial epithelial cell line.Exploring the anticancer potential of pyrazolo[1,2-a]benzo[1,2,3,4]tetrazin-3-one derivatives: the effect on apoptosis induction, cell cycle and proliferation.Selective depression of interferon-gamma and granulysin production with increase of proliferative response by Vgamma9/Vdelta2 T cells in children with tuberculosis.Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo.FACIT collagen (1alpha-chain) is expressed by hemocytes and epidermis during the inflammatory response of the ascidian Ciona intestinalis.A continuous infusion of a minor histocompatibility antigen-immunodominant peptide induces a delay of male skin graft rejection.Cigarette smoke alters IL-33 expression and release in airway epithelial cells.IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases.Increased levels of Th17 cells are associated with non-neuronal acetylcholine in COPD patientsBudesonide increases TLR4 and TLR2 expression in Treg lymphocytes of allergic asthmaticsBroad clonal heterogeneity of antigen-specific CD4+ T-cells localizing at the site of disease during tuberculosisCytokine profile, HLA restriction and TCR sequence analysis of human CD4+ T clones specific for an immunodominant epitope of Mycobacterium tuberculosis 16-kDa proteinChange of Th0 to Th1 cell-cytokine profile following tuberculosis chemotherapyDifferential activation of human gammadelta cells by nonpeptide phosphoantigensWhole body irradiation induces IFN-gamma production in BALB/c mice by preventing the appearance of a V alpha 14(+)NK T downregulatory populationIdentification of epitopes of Mycobacterium tuberculosis 16-kDa protein recognized by human leukocyte antigen-A*0201 CD8(+) T lymphocytesSequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapyDifferent role of human HLA-DR and -DQ molecules in xenogeneic transplantation using transgenic micePivotal advance: alpha-galactosylceramide induces protection against lipopolysaccharide-induced shockAnalysis of the immune response induced by a single xenoantigen in vivoAltered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions
P50
Q34515612-EFFC37F8-8108-46CF-908B-7D07F9E8EB7FQ34661658-CA25CACE-DBFC-44C6-B88B-1C9EB10000DDQ38850701-3811814A-7DFF-4E43-B24E-2DAEE783EBC0Q38998429-1A6DD7C1-7931-4501-85B8-E676012FA522Q39015842-00F40E61-7B8F-48A4-9E73-4A2F36B49D6DQ39078173-B83F1455-5F1C-4B6C-984B-3C65250577EFQ39106492-B2D618A1-E6F1-400D-B069-619C8A711D35Q39133499-C24F9B02-40C0-452D-8A13-4AC9BE5750F5Q39156263-A0A5EBB2-B7C5-4707-98C9-35E9BB89F796Q44267506-2854B6AD-A77B-4EF3-98C7-B987B0C3B069Q44575984-F61C7179-D862-48A9-A0B5-047D6EAE3FC0Q46876742-2E10B505-5DE3-471E-B905-EFD9B4B05936Q51653675-D75B9312-ACE1-414E-B78D-C09F93C4B391Q51716887-4613A6ED-07A8-4877-8593-03111DF1FE50Q52961208-9DBCE3F3-2749-45E0-AD06-D702C41745D7Q59226943-163F555B-D470-42E2-9203-044DA74CCEE4Q60540781-DC7DB6E7-F79A-4D3E-B914-C30C60744183Q73100412-AEA0F6A5-643B-4FAA-BF10-7581EF5A3723Q73686015-1BD29682-C4ED-43D6-89AC-9299BB87677CQ73969883-ED45A3D8-2325-4545-A7A3-92760E8E06E8Q74240738-62A538EA-9D74-4782-AE15-DD7CBFC85957Q74280620-A18A553D-BCEE-45D8-8531-39B0005B53E6Q74791165-3494EE11-6488-4821-B335-CBB8D8C8DC1CQ77828348-73AAB45A-AD35-475E-980B-4062C649BF7EQ78106890-A31CEF54-7EA5-41DD-BDB4-83B3DF43D6CDQ79259827-F1ECB4CE-8317-44AA-BFEB-05714BACC8EDQ81697947-B537CF06-89FD-47A7-8339-6604B37B1495Q85173938-AC890326-1DDF-4B3E-A0B5-811081009BCF
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Caterina Di Sano
@ast
Caterina Di Sano
@en
Caterina Di Sano
@es
Caterina Di Sano
@nl
type
label
Caterina Di Sano
@ast
Caterina Di Sano
@en
Caterina Di Sano
@es
Caterina Di Sano
@nl
prefLabel
Caterina Di Sano
@ast
Caterina Di Sano
@en
Caterina Di Sano
@es
Caterina Di Sano
@nl
P106
P1153
56530887400
P21
P31
P496
0000-0003-3904-3465